Tenecteplase comment watch save

  • TRADE NAME: TNKase (Genentech)
  • INDICATIONS: Acute myocardial infarction
  • CLASS: Fibrinolytic
  • HALF-LIFE: 90–130 minutes
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    Bivalirudin

Please login to view the rest of this drug profile.

Page last updated 07/31/2023

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top